Vocimagene amiretrorepvec Uses, Dosage, Side Effects and more
Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)).
| Trade Name | Vocimagene amiretrorepvec |
| Generic | Vocimagene amiretrorepvec |
| Vocimagene amiretrorepvec Other Names | Vocimagene amiretrorepvec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
